Glyoxal, solution à 40 %, 100 ml, conditionnement en verre

3-o-Tolyl-prop-2-yn-1-ol, 250mg

3-Chloroindole, 95.0%, 500mg

(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate, 98%, 10g

(R)-4-Benzyloxazolidine-2-thione, 97%, 1g

2,4-Dichloro-N-cyclopropyl-N-piperidin-4-ylmethyl-benzenesulfonamide hydrochloride, 95.0%, 100mg

6-Oxopiperidine-3-carboxylic acid, 95.0%, 1g

2,4-Dichloro-6-methyl-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 250mg

Fmoc-Cys(Trt)-OH, 98%, 500g

2-Benzyl-5-bromo-1,2,3,4-tetrahydro-[2,6]naphthyridine, 95.0%, 500mg

3,4-Difluorobenzonitrile, 98.0%, 1g

3-(4-Aminophenyl)-3-oxopropanenitrile, 98%, 250mg

Boîtes de Pétri sans cames d'aération, Non stériles 480 pcs